LQDA · Liquidia Corp
United States · RS rating 53 · As of 2026-11-03
| Price | 42.20 USD |
|---|---|
| 1-day change | +0.8% |
| RS rating (overall / 1M / 3M / 12M) | 53 / 98 / 8 / 91 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 41 / 28 / 43 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +246.7% |
| Sales growth Q/Q | +69.3% |
| Distance from 52-week high | +53.6% |
| Market cap (USD) | $3.3B |